TRANSCEND-T2D-1 (NCT06354660) will compare the efficacy and safety of retatrutide compared to placebo in people with inadequately controlled T2D treated with diet and exercise over a period of 11 months
"Individuals with type 1 can work with their medical teams to determine whether GLP-1 receptor agonists may be beneficial for obesity treatment or glycemic management," Van Name said
Unlike full-length growth hormone, AOD-9604 does not upregulate IGF-1, does not induce insulin resistance in reported toxicology models, and does not measurably affect linear growth in adult animal models
Tirzepatide (Mounjaro) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist currently licensed for diabetes in the UK
Using patented technology,LivOn wrap the Setria Glutathione molecules in double-layered phospholipid spheres (liposomes) that protect the antioxidant through the digestive system and transport it into the bloodstream for absorption in the cells
Those closer to their goal weight may lose more slowly but still benefit from the medication